Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme 2

Michael Quagliata; Maria Alfreda Stincarelli; Anna Maria Papini; Simone Giannecchini; Paolo Rovero

doi:10.1021/acsomega.3c01436

journal article Open Access Jun 13, 2023

Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme 2

Michael Quagliata

Maria Alfreda Stincarelli Anna Maria Papini

Simone Giannecchini Paolo Rovero

ACS Omega Vol. 8 No. 25 pp. 22665-22672 · American Chemical Society (ACS)

View at Publisher Save 10.1021/acsomega.3c01436

Topics

No keywords indexed for this article. Browse by subject →

References

53

[1]

World Health Organization. Weekly epidemiological update on COVID-19 - 21 December 2022 https://www.who.int/publications/m/item/covid-19-weekly-epidemiological-update-21-december-2022 (accessed Dec 26, 2022).

[2]

10.1136/bmj-2021-068632

[3]

10.1093/ajhp/zxab344

[4]

10.1016/j.trsl.2019.12.002

[5]

Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis

Florian Kabinger, Carina Stiller, Jana Schmitzová et al.

Nature Structural & Molecular Biology 10.1038/s41594-021-00651-0

[6]

10.1038/s41594-021-00657-8

[7]

An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19

Dafydd R. Owen, Charlotte M. N. Allerton, Annaliesa S Anderson et al.

Science 10.1126/science.abl4784

[8]

10.3390/ijms22179124

[9]

10.1021/acscentsci.2c00369

[10]

A Synthetic Peptide from HIV-1 gp41 Is a Potent Inhibitor of Virus-Mediated Cell—Cell Fusion

Carl Wild, Teresa Greenwell, Thomas Matthews

AIDS Research and Human Retroviruses 10.1089/aid.1993.9.1051

[11]

10.1074/jbc.m110.207084

[12]

Mechanisms of SARS-CoV-2 entry into cells

Cody B. Jackson, Michael Farzan, Bing Chen et al.

Nature Reviews Molecular Cell Biology 10.1038/s41580-021-00418-x

[13]

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp, Nianshuang Wang, Kizzmekia S. Corbett et al.

Science 10.1126/science.abb2507

[14]

10.1016/j.bpj.2021.02.007

[15]

Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site

Javier A. Jaimes, Jean K. Millet, Gary R. Whittaker

iScience 10.1016/j.isci.2020.101212

[16]

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Shuai Xia, Yun Zhu, Meiqin Liu et al.

Cellular & Molecular Immunology 10.1038/s41423-020-0374-2

[17]

10.1016/j.phrs.2021.105982

[18]

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan, Yuanyuan Zhang, Yaning Li et al.

Science 10.1126/science.abb2762

[19]

Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion

Donald J. Benton, Antoni G. Wrobel, Pengqi Xu et al.

Nature 10.1038/s41586-020-2772-0

[20]

10.1021/acs.jmedchem.1c00477

[21]

10.1021/acs.bioconjchem.0c00664

[22]

10.1021/acsnano.0c02857

[23]

Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD

G. Zhang, S. Pomplun, A. R. Loftis et al.

10.1101/2020.03.19.999318

[24]

A Helix Propensity Scale Based on Experimental Studies of Peptides and Proteins

C. Nick Pace, J. Martin Scholtz

Biophysical Journal 10.1016/s0006-3495(98)77529-0

[25]

10.1038/s42003-021-01736-8

[26]

10.3390/molecules26082157

[27]

10.1002/anie.201302014

[28]

10.1002/cbic.202200372

[29]

10.1021/acs.jmedchem.2c01541

[30]

10.1002/anie.201310245

[31]

10.1039/d0cc08387a

[32]

Equilibrium Ring-Closing Metathesis

Sebastien Monfette, Deryn E. Fogg

Chemical Reviews 10.1021/cr800541y

[33]

10.1128/mbio.02451-20

[34]

10.1016/j.ejmech.2023.115118

[35]

10.1016/j.peptides.2021.170638

[36]

10.1016/j.csbj.2022.04.030

[37]

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

Longxing Cao, Inna Goreshnik, Brian Coventry et al.

Science 10.1126/science.abd9909

[38]

10.3390/ijms23116309

[39]

10.1021/acs.jproteome.0c00686

[40]

10.3389/fphar.2021.731828

[41]

10.1016/j.trechm.2020.03.007

[42]

10.1021/cr0783479

[43]

10.2174/1568026618666180518095755

[44]

10.1021/jo800142s

[45]

10.1021/jm501027w

[46]

10.1016/j.bmcl.2009.09.049

[47]

Design of Triazole-Stapled BCL9 α-Helical Peptides to Target the β-Catenin/B-Cell CLL/lymphoma 9 (BCL9) Protein–Protein Interaction

Steven A. Kawamoto, Adriana Coleska, Xu Ran et al.

Journal of Medicinal Chemistry 10.1021/jm201125d

[48]

10.1002/ejoc.200901157

[49]

10.1002/pep2.24159

[50]

10.1046/j.1432-1327.1999.00641.x

Showing 50 of 53 references

Cited By

16

A review on current status of antiviral peptides

Abid Qureshi · 2025

Discover Viruses

Metrics

16

Citations

53

References

Details

Published: Jun 13, 2023
Vol/Issue: 8(25)
Pages: 22665-22672
License: View

Authors

M

Michael Quagliata

Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry “Ugo Schiff”, University of Florence, 50019 Sesto Fiorentino, Italy

M

Maria Alfreda Stincarelli

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy

A

Anna Maria Papini

Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry “Ugo Schiff”, University of Florence, 50019 Sesto Fiorentino, Italy

S

Simone Giannecchini

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy

P

Paolo Rovero

Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of NeuroFarBa, University of Florence, 50019 Sesto Fiorentino, Italy

Cite This Article

Michael Quagliata, Maria Alfreda Stincarelli, Anna Maria Papini, et al. (2023). Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme 2. ACS Omega, 8(25), 22665-22672. https://doi.org/10.1021/acsomega.3c01436

Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme 2

You May Also Like